Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2001
11/29/2001WO2001090148A2 Neurotransmitter transporters
11/29/2001WO2001090147A2 Long wavelength engineered fluorescent proteins
11/29/2001WO2001090143A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
11/29/2001WO2001090135A1 Drug-amino acids sequence chimeric molecules
11/29/2001WO2001090127A2 Haplotypes of the hoxd3 gene
11/29/2001WO2001090126A2 Haplotypes of the snap29 gene
11/29/2001WO2001090124A2 Haplotypes of the gpr31 gene
11/29/2001WO2001090123A2 Haplotypes of the agtrl1 gene
11/29/2001WO2001090120A2 Haplotypes of the evx1 gene
11/29/2001WO2001090118A2 Haplotypes of the edn2 gene
11/29/2001WO2001090117A2 Haplotypes of the p2ry1 gene
11/29/2001WO2001090116A2 Haplotypes of the apobec2 gene
11/29/2001WO2001090115A2 Haplotypes of the cdk4 gene
11/29/2001WO2001089581A1 Medicinal compositions containing prostacyclin synthase gene
11/29/2001WO2001089568A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001WO2001089364A2 Hcv variants
11/29/2001WO2001089303A1 Methods of modulating the activity of mura
11/29/2001WO2001074405B1 Gene expression profiles in esophageal tissue
11/29/2001WO2001055173A8 Nucleic acids, proteins, and antibodies
11/29/2001WO2001051669A9 Nucleic acid binding assay and selection method
11/29/2001WO2001044280A3 Methods and compositions for the manufacture of replication incompetent adenovirus
11/29/2001WO2001043869A3 Cell arrays and the uses thereof
11/29/2001WO2001043764A3 Methods for treating pervasive development disorders
11/29/2001WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001WO2001042446A3 A functional gene array in yeast
11/29/2001WO2001040491A3 Udp-glucose:aglycon-glucosyltransferase
11/29/2001WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001WO2001038566A3 Screening method for candidate drugs
11/29/2001WO2001034806A3 Methods and compositions for screening using diphtheria toxin constructs
11/29/2001WO2001033217A3 Monitoring the activity of factor xa inhibitors
11/29/2001WO2001031007A3 Nucleic acid molecules derived from rat brain and programmed cell death models
11/29/2001WO2001029264A3 Nucleic acid primers and probes for detecting tumor cells
11/29/2001WO2001029253A3 Simultaneous visualization of eu- and heterochromatin
11/29/2001WO2001029234A3 Self-cleaving rna sequences and their use for the control of protein synthesis
11/29/2001WO2001029064A8 Melanoma antigens and methods of use
11/29/2001WO2001028684A3 System and method for filling a substrate with a liquid sample
11/29/2001WO2001025471A3 Method for the detection of antimicrobial residues
11/29/2001WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001WO2001025246A3 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same
11/29/2001WO2001023590A3 22196, a novel human aminopeptidase
11/29/2001WO2001020029A3 Genetic markers of toxicity, preparation and uses thereof
11/29/2001WO2001016357A3 Novel target for antiparasitic agents and inhibitors thereof
11/29/2001WO2001006257A8 Metal nanoshells for biosensing applications
11/29/2001WO2001000864A3 Nucleic acid binding of multi-zinc finger transcription factors
11/29/2001WO2001000826A3 Novel molecules of the card-related protein family and uses thereof
11/29/2001WO2000073469A3 Protein kinases
11/29/2001WO2000061597A9 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
11/29/2001WO2000043505A3 Protease with two aspartate radicals in the catalytically active structure
11/29/2001WO2000040722A3 Insulin-synthesis genes
11/29/2001US20010047526 Mapping molecular interactions in plants with protein fragments complementation assays
11/29/2001US20010047080 Inhibits hiv infection of cells
11/29/2001US20010047078 Methods for identifying inhibitors of methionine aminopeptidases
11/29/2001US20010047077 Nucleic acid analogs with a chelating functionality
11/29/2001US20010046714 Table for binding components of a sample, such as nucleic acids, comprising magnetic particles and an excipient that links the particles; useful in analysis of liquids
11/29/2001US20010046707 Enhancing the competence of a cell through production of a library of recombinant genes
11/29/2001US20010046706 Controlled electroporation and mass transfer across cell membranes
11/29/2001US20010046700 Fluid control module and temperature controller
11/29/2001US20010046699 Apparatus for positioning substances for detection and film for positioning substances for detection and manufacturing method of carrier for substances for detection
11/29/2001US20010046694 1-deoxy-D-xylulose-5-phosphate reductoisomerases, and methods of use
11/29/2001US20010046689 Processeing microscopic images to provide numerical data as an indicator
11/29/2001US20010046688 Substrate of an oxidant, stabilizer and buffer with an extended shelf life is useful with enzyme based probes; detecting DNA fragments in DNA sequencing
11/29/2001US20010046687 Stabilized by adding trehalose to its saturation solubility; microorganism detection for cleanliness of food preparation areas
11/29/2001US20010046682 Presence of a target reactant is determined by measuring the amount of material bound to an immobilized reactant
11/29/2001US20010046681 Shot-gun sequencing and amplification without cloning
11/29/2001US20010046679 Site-selective nucleic acid modification with redox active transition metal complexes
11/29/2001US20010046678 Dissociating a solution of double stranded nucleic acid into single strands to measure UV absorption and acquiring a thermal melting profile
11/29/2001US20010046677 Method for detecting mutations in nucleic acids
11/29/2001US20010046676 Integrated sequencing device
11/29/2001US20010046674 Upon binding a ligand to a signal generated by a reporter molecule, detecting and quantifying the ligand in solution
11/29/2001US20010046673 Illuminating a nucleic acid sample, detecting light transmission and determining presence, absence, or identity of the target
11/29/2001US20010046671 Hybridizing gene sequences from biological processes with probes and determining and identifying genes that are differentially expressed; contains only gene sequences of interest in a particular area
11/29/2001US20010046670 Single stranded DNA sequence hybridizes an oligonucleotide or DNA analogue and then complexes with a marker; output signals are measured for formation and dissociation indications
11/29/2001US20010046669 Genetically filtered shotgun sequencing of complex eukaryotic genomes
11/29/2001US20010046668 Binding an anchor to a substrate with a fluorescent radical attached; virus detection
11/29/2001US20010046667 Determination of latent HIV infection
11/29/2001US20010046665 Method of identifying the function of a test agent
11/29/2001US20010046663 A compound is attached to a solid support and enzyme binding is assessed with/without the presence of metal; modulation detection
11/29/2001US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
11/29/2001US20010045359 Separation of cell particle by dielectrophoresis
11/29/2001EP1144603A3 Protease
11/29/2001DE10024174A1 Verfahren zum Selektieren von Inhibitoren für Enzyme A method of selecting inhibitors for enzymes
11/29/2001DE10023743A1 Peptidsubstrate zur direkten Messung enzymatischer Aktivitäten Peptide substrates for the direct measurement of enzymatic activities
11/29/2001CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001CA2429199A1 Drug metabolizing enzymes
11/29/2001CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001CA2410317A1 Methods for assaying gene imprinting and methylated cpg islands
11/29/2001CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001CA2410094A1 Compositions and methods for modulating tumor specific expression
11/29/2001CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods
11/29/2001CA2410081A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/29/2001CA2409873A1 Hcv variants
11/29/2001CA2409774A1 Methods for genetic analysis of dna to detect sequence variances
11/29/2001CA2409772A1 Antiviral therapy
11/29/2001CA2409309A1 Materials and methods for detection of nucleic acids
11/29/2001CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001CA2408749A1 Drug screening systems and assays
11/29/2001CA2408743A1 Method of detecting inflammatory lung disorders
11/29/2001CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001CA2408728A1 Compositions and methods for nucleic acid or polypeptide analyses